Raymond James Financial Services Advisors, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,374
-70.5%
25,632
-36.1%
0.00%
Q2 2023$52,134
-60.1%
40,103
-46.0%
0.00%
Q1 2023$130,780
-48.0%
74,307
-7.2%
0.00%
-100.0%
Q4 2022$251,461
-39.1%
80,083
-5.0%
0.00%0.0%
Q3 2022$413,000
+15.4%
84,326
-2.6%
0.00%0.0%
Q2 2022$358,000
-33.6%
86,590
-6.7%
0.00%0.0%
Q1 2022$539,000
-41.5%
92,792
-24.5%
0.00%
-50.0%
Q4 2021$922,000
-56.1%
122,957
-47.3%
0.00%
-50.0%
Q3 2021$2,101,000
-30.3%
233,223
-7.4%
0.00%
-33.3%
Q2 2021$3,015,000
-0.8%
251,851
+3.8%
0.01%
-14.3%
Q1 2021$3,040,000
-3.0%
242,584
+20.8%
0.01%
-12.5%
Q4 2020$3,134,000
+451.8%
200,841
+233.9%
0.01%
+300.0%
Q3 2020$568,0000.0%60,158
-5.2%
0.00%0.0%
Q2 2020$568,000
+93.9%
63,448
+38.1%
0.00%
+100.0%
Q1 2020$293,000
+168.8%
45,952
+280.4%
0.00%
Q3 2019$109,000
-19.9%
12,080
-4.4%
0.00%
-100.0%
Q2 2019$136,000
+18.3%
12,632
+5.0%
0.00%
Q1 2019$115,000
-8.0%
12,030
+10.1%
0.00%
-100.0%
Q4 2018$125,000
-76.7%
10,930
-65.4%
0.00%
-50.0%
Q3 2018$536,000
+60.0%
31,595
+34.0%
0.00%0.0%
Q2 2018$335,000
+1.8%
23,570
+36.1%
0.00%0.0%
Q1 2018$329,000
+5.8%
17,320
-8.7%
0.00%0.0%
Q4 2017$311,000
+41.4%
18,962
+29.3%
0.00%
+100.0%
Q3 2017$220,000
+197.3%
14,662
+14.7%
0.00%0.0%
Q2 2016$74,00012,7830.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders